The phenomenon of lineage switch is one of the causes of resistance to CD19 CAR-T therapy, mainly in mixed lineage leukemia (MLL)-rearranged B-ALL [111,112,113], however, one case was also detected in a Philadelphia chromosome-positive B-ALL patient [114]. Here, KMT2A is linked to acute lymphoblastic leukemia.